US STOCK
ELV Stock Analysis
US stocks · market data · technical indicators
Elevance Health, Inc.
ELVUS stocksQuote delayed 15 min
9/11 下午05:51 updated
$416.54
+19.64+4.95%
Open
$407.38
High
$421.90
Low
$406.00
Volume
190.43萬
ELV price history
+4.60%Open
398.22
Latest
416.54
High
416.54
Low
390.24
Average
400.95
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score85
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
BuyCurrent Price$416.54
Target Price$562.329
Change %+4.95%
Institutional
Flat
Foreign Ownership
Flat
Market Heat
Strong
Fundamentals (US)
P/E Ratio
18.41x
ROE
11.13%
P/B Ratio
2.01x
Dividend Yield
1.65%
Market Insight
The composite score points to a strong buy signal (85/100), with several technical and fundamental indicators in positive territory. Notable price movement today (+4.95%), indicating increased market attention. The target price implies roughly 35.00% upside.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
ELV - Elevance Health, Inc.
EPS
22.62USD
Forward EPS
29.61USD
P/E
18.41x
Forward P/E
14.07x
P/B
2.01x
ROE
11.13%
ROA
3.83%
Operating margin
4.56%
Profit margin
2.47%
Revenue growth
1.40%
Earnings growth
-13.10%
Dividend yield
1.65%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B |
| Net income | $1.46B | $1.76B | $547.00M | $1.19B | $1.74B |
| Basic EPS | 6.75 | 8.12 | 2.48 | 5.35 | 7.75 |
| Diluted EPS | 6.71 | 8.00 | 2.47 | 5.32 | 7.72 |
Estimates vs actuals
Next earnings
2026-10-21
EPS estimate
4.66
Revenue estimate
$49.12B
Last surprise
+19.99%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-21 | 4.66 | Not reported | — |
| 2026-07-15 | 6.21 | 7.45 | +19.99% |
| 2026-04-22 | 10.81 | 12.58 | +16.36% |
| 2026-01-28 | 3.09 | 3.33 | +7.65% |
| 2025-10-21 | 4.94 | 6.03 | +22.01% |
| 2025-07-17 | 8.92 | 8.84 | -0.91% |
| 2025-04-22 | 11.48 | 11.97 | +4.30% |
| 2025-01-23 | 3.85 | 3.84 | -0.29% |
| 2024-10-17 | 9.65 | 8.37 | -13.28% |
| 2024-07-17 | 10.01 | 10.12 | +1.14% |
| 2024-04-18 | 10.53 | 10.64 | +1.08% |
| 2024-01-24 | 5.59 | 5.62 | +0.62% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $11.2B | 0.25% |
| VANGUARD GROUP INC | 2025-12-31 | $8.1B | 0.12% |
| STATE STREET CORP | 2026-06-30 | $4B | 0.12% |
| CITADEL ADVISORS LLC | 2026-06-30 | $350.5M | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $77.9M | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $62.7M | 0.05% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$450.05
Target range
$393.00 – $492.00
Implied upside
8.04%
Strong buy
3
Buy
12
Hold
7
Sell
0
Strong sell
0
Dividends
Annual yield
1.24%
Frequency
Quarterly
Recent payouts
- 2026-06-10$1.7200
- 2026-03-10$1.7200
- 2025-12-05$1.7100
- 2025-09-10$1.7100
Advertisement